跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TAFINLAR 50MG CAPSULE(28) - SFDA Drug Approval Details
Approvals
/
SFDA
/
TAFINLAR 50MG CAPSULE(28)
Authorized
NCE
TAFINLAR 50MG CAPSULE(28)
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
95b2c0d8fe265a65
Company
Unknown
Type
NCE
Approval Details
Approval Id
95b2c0d8fe265a65
Drug Approval Sfda Name
TAFINLAR 50MG CAPSULE(28)
Trade Name
TAFINLAR 50MG CAPSULE(28)
Generic Name
DABRAFENIB MESILATE
Register Number
2905245377
Register Year
2018
Drug Type
NCE
Route Of Administration
Oral use
Package Type
Bottle
Package Size
28
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
store below 30°c
Shelf Life
24 Months
Distribution Site
Hospital
Description Code
7000000341-50-100000073375
Price
2821.45
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
95b2c0d8fe265a65
Type
NCE
Back to SFDA Approvals